News Results 1-10 of 5,718

Sponsored Links

Diseases musculoskeletal

Relax. Take a deep breath. We have the answers you seek.

www.RightHealth.com/Rheumatology

Buy the Book from Amazon

The musculoskeletal system Free US Shipping Available

www.amazon.com

Genmab Reaches GSK Milestone

News  |  www.contractpharma.com | 1 hour 11 minutes ago

Genmab has reached the sixth milestone in its collaboration with GlaxoSmithKline for ofatumumab (HuMax-CD20), as the first patient received treatment in the Phase I study of ofatumumab in relapsed/refractory follicular non-Hodgkin's lymphoma and chronic lymphocytic leukemia in Japan.

http://www.contractpharma.com/news/2008/10/13/genmab_reaches_gsk_milestone

[$$] Glaxo Has an Antidote to Market Volatility (at RealMoney by TheStreet.com)

News  |  www.thestreet.com | 3 hours 31 minutes ago

Glaxo Has an Antidote to Market Volatility, Its drug development pipeline is full, it pays a nice dividend, and Buffett is on board.

http://www.thestreet.com/p/_yahoo/rmoney/pharmaceuticals/10441931.html?cm_ven=YAHOO&cm_cat=PREMIUM&cm_ite=003190

Biodel Receives Notice of Allowance for Insulin Patent Claims in Europe (Business Wire)

News  |  biz.yahoo.com | 3 hours 37 minutes ago

Biodel Receives Notice of Allowance for Insulin Patent Claims in Europe. - DANBURY, Conn.--(BUSINESS WIRE)--Biodel Inc. (Nasdaq: BIOD - News) announced today that it has received a notice of allowance from the European Patent Office for patent claims covering compositions and uses of formulations

http://biz.yahoo.com/bw/081013/20081013005326.html?.v=1

Irish Medical Times | Clinical TImes | Doctors miss their chance to empathise

News  |  www.imt.ie | Oct 11, 2008

A small study has found that doctors seldom respond empathetically to concerns raised by patients with lung cancer. In the study, doctors analysed 20 recorded and transcribed consultations between lung cancer patients and nine doctors.

http://www.imt.ie/clinical/cancer/doctors-miss-their-chance-to-e.html

Genmab A/S has Reached the Sixth Milestone in Ofatumumab Collaboration With GlaxoSmithKline; Recieves $5.6M from

News  |  www.biospace.com | Oct 10, 2008

COPENHAGEN, Denmark, October 10 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN) announced today it has reached the sixth milestone for ofatumumab (HuMax-CD20(R)) under the terms of its collaboration with GlaxoSmithKline (GSK). A milestone payment of approximately DKK 29 million (approximately

http://www.biospace.com/news_story.aspx?StoryID=112674&full=1

EntreMed to Present at BioPartnering Europe Conference

Press Release  |  www.prnewswire.com | Oct 10, 2008

ROCKVILLE, Md., Oct. 10 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD) a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, announced today that Thomas H. Bliss, Jr.

http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/10-10-2008/0004901664&EDATE=

[RESEARCH] Does a functional activity programme improve function, quality of life, and falls for residents in long term care? Cluster randomised controlled trial

News  |  www.bmj.com | Oct 9, 2008

Objective To assess the effectiveness of an activity programme in improving function, quality of life, and falls in older people in residential care.Design Cluster randomised controlled trial with one year follow-up.Setting 41 low level dependency residential

http://www.bmj.com/cgi/content/full/337/oct09_3/a1445?rss=1

Get 2 1/2 hours of exercise per week, U.S. says

News  |  uk.reuters.com | Oct 8, 2008

WASHINGTON (Reuters) - Adults should aim to get in 2 1/2 hours of exercise a week and children should run and play for at least an hour a day, according to new exercise guidelines issued by the U.S. government

http://uk.reuters.com/article/healthNews/idUKTRE4967IV20081008?feedType=RSS&feedName=healthNews

Will a Better Drug Sell Better? (at Motley Fool)

News  |  www.fool.com | Oct 7, 2008

The Motley Fool - Positive trial data isn't enough to significantly boost Johnson Johnson's Remicade.

http://www.fool.com/investing/dividends-income/2008/10/07/will-a-better-drug-sell-better.aspx

Biogen drug has strong clinical showing as leukemia medicine

News  |  www.bizjournals.com | Oct 7, 2008

Cambridge, Mass.-based Biogen Idec (Nasdaq: BIIB) partners with California-based Genentech (NYSE: DNA) to market Rituxan in the United States. Biogen has about 750 workers in Research Triangle Park, where it makes the multiple sclerosis drug Tysabri.

http://www.bizjournals.com/triangle/stories/2008/10/06/daily17.html?ana=from_rss

Sponsored Links

Musculoskeletal System

Musculoskeletal system Save on exactly what you need!

www.half.com

Musculoskeletal System

Breaking News, Expert Tips, Member Support, Treatment Options & More

EverydayHealth.com

Musculoskeletal System

Learn The Symptoms & Treatments Of Ilinesses On Ask.com. Try It Now!

www.ask.com

Results 1-10 of 5,718

Want to put this widget on your blog or personal homepage? Choose your site from the list below.
Add to Google
Or copy the embed script code below and paste it on your website:
Embed code:
>

Refine by Content Type:

  • Refined by: News  

Refine by Source:

Choose a source :

Close

100 Sources ...

Refine by Company:

Choose a company :

Close

56 Companies ...